-
Redken recalls spray mousse foam cans
NEW YORK — Redken has announced that it is recalling spray mousse foam cans sold at beauty supply stores and hair salons because of potential rupture.
Over time the aerosol containers' inside lining can corrode, creating the potential risk of rupturing and releasing the contents. Nearly 1 million cans have been recalled, according to the manufacturer.
-
FDA approves Actemra as arthritis treatment for children
SOUTH SAN FRANCISCO, Calif. — The Food and Drug Administration has approved a drug made by Genentech for treating a rare and severe form of arthritis that affects children, Genentech said.
The biotech company, the U.S. division of Swiss drug maker Roche, announced the FDA approval of Actemra (tocilizumab) for active systemic juvenile idiopathic arthritis. SJIA has the worst long-term prognosis of all varieties of childhood arthritis.